BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25617926)

  • 1. Stem cells create a therapeutic niche.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926
    [No Abstract]   [Full Text] [Related]  

  • 2. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tempering hope with realism: induced pluripotent stem cells in regenerative medicine.
    Fung RK; Kerridge IH; Skene LL; Munsie MJ
    Med J Aust; 2012 Jun; 196(10):622-5. PubMed ID: 22676869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic stem cells and iPS cells: sources and characteristics.
    Hackett CH; Fortier LA
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):233-42. PubMed ID: 21872756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REGENERATIVE MEDICINE. California stem cell agency plots a race to the clinic.
    Servick K
    Science; 2016 Jan; 351(6268):15. PubMed ID: 26721984
    [No Abstract]   [Full Text] [Related]  

  • 9. Lancet Commission: Stem cells and regenerative medicine.
    Cossu G; Birchall M; Brown T; De Coppi P; Culme-Seymour E; Gibbon S; Hitchcock J; Mason C; Montgomery J; Morris S; Muntoni F; Napier D; Owji N; Prasad A; Round J; Saprai P; Stilgoe J; Thrasher A; Wilson J
    Lancet; 2018 Mar; 391(10123):883-910. PubMed ID: 28987452
    [No Abstract]   [Full Text] [Related]  

  • 10. The inherent ethical challenge of first-in-human pluripotent stem cell trials.
    Habets MG; van Delden JJ; Bredenoord AL
    Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
    Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
    Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells.
    Behr B; Ko SH; Wong VW; Gurtner GC; Longaker MT
    Plast Reconstr Surg; 2010 Oct; 126(4):1163-1171. PubMed ID: 20555302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cutting-edge of medicine: progress and prospects: induced pluripotent stem cell research for neurological diseases].
    Ito D; Suzuki N
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3230-6. PubMed ID: 24605575
    [No Abstract]   [Full Text] [Related]  

  • 14. Will it be possible to generate kidney tissue from induced pluripotent stem cells for regenerative therapy?
    Osafune K
    Regen Med; 2014 Jan; 9(1):9-12. PubMed ID: 24351001
    [No Abstract]   [Full Text] [Related]  

  • 15. Concise review: cell therapy and tissue engineering for cardiovascular disease.
    Haraguchi Y; Shimizu T; Yamato M; Okano T
    Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good practice.
    Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
    [No Abstract]   [Full Text] [Related]  

  • 17. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.